插管时呼气末二氧化碳及其复苏10分钟后升高可预测院外心脏骤停患者生存且神经功能预后良好
该研究纳入2015至2018年意大利帕维亚省和瑞士提契诺州所有连续院外心脏骤停患者668例,评估插管时呼气末二氧化碳(ETCO2)及其插管后10分钟升高能否预测入院生存、出院生存及神经功能良好预后(CPC 1-2)。结果显示插管时ETCO2>20 mmHg及其10分钟后升高是入院生存和出院生存的独立预测因子;对出院时神经功能良好预后,插管时ETCO2(OR 1.83,95%CI 1.02-3.3;p=0.04)和10分钟变化(OR 3.9,95%CI 1.97-7.74;p<0.001)均为预测因子,进一步校正旁观者及心肺复苏状态、初始心律和急救到达时间后,ETCO2变化仍为独立预测因子。作者认为复苏期间ETCO2升高比插管时ETCO2预测力更强,并认为需更大规模前瞻性研究证实。
要点
- 院外心脏骤停患者插管时ETCO2>20 mmHg是入院生存和出院生存的独立预测因子。
- 插管后10分钟ETCO2升高同样独立预测入院生存和出院生存。
- 对出院时神经功能良好预后(CPC 1-2),插管时ETCO2的OR为1.83(95%CI 1.02-3.3;p=0.04)。
- 对出院时神经功能良好预后,10分钟ETCO2变化的OR为3.9(95%CI 1.97-7.74;p<0.001),预测力强于插管时ETCO2。
- 校正性别、年龄、病因和地点后结论仍成立;进一步校正旁观者及心肺复苏状态、初始心律和急救到达时间后,ETCO2变化仍为独立预测因子。
适用人群与场景
- 2015至2018年意大利帕维亚省和瑞士提契诺州所有连续院外心脏骤停患者,任何病因。
- 排除救护车到达前已死亡、有「不复苏」医嘱、无ETCO2数值或数据不完整的患者。
诊断标准与关键阈值
- 插管时ETCO2>20 mmHg为预测界值。
- 插管后10分钟ETCO2升高为预测指标。
研究设计与关键结果
- 研究类型为2015至2018年意大利帕维亚省和瑞士提契诺州连续院外心脏骤停患者的观察性研究,样本量668例。
- 插管时ETCO2>20 mmHg及其插管后10分钟升高,在校正已知院外心脏骤停预后预测因子后,是入院生存和出院生存的独立预测因子。
- 对出院时神经功能良好预后(CPC 1-2),插管时ETCO2的OR为1.83(95%CI 1.02-3.3;p=0.04),10分钟ETCO2变化的OR为3.9(95%CI 1.97-7.74;p<0.001),二者单独及双变量分析中均为预测因子。
- 校正性别、年龄、病因和地点后上述结果仍成立。
- 进一步校正旁观者及心肺复苏状态、初始心律和急救到达时间后,ETCO2变化仍为独立预测因子。
- 作者结论:复苏期间ETCO2升高比插管时ETCO2预测力更强。
证据类型、等级与局限
- 证据类型:观察性研究(连续纳入的院外心脏骤停患者队列)。
- 局限:作者认为需更大规模前瞻性研究证实该发现。
对床旁实践的改变
- 对院外心脏骤停患者,插管时ETCO2>20 mmHg且插管后10分钟内ETCO2升高,提示入院生存、出院生存及出院时神经功能良好预后(CPC 1-2)的可能性更高。
- 作者认为复苏期间ETCO2升高比插管时ETCO2是更强的预测指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To evaluate whether end-tidal carbon dioxide (ETCO2) value at intubation and its early increase (10 min) after intubation predict both the survival to hospital admission and the survival at hospital discharge, including good neurological outcome (CPC 1-2), in patients with out-of-hospital cardiac arrest (OHCA).
METHODS: All consecutive OHCA patients of any etiology between 2015 and 2018 in Pavia Province (Italy) and Ticino Region (Switzerland) were considered. Patients died before ambulance arrival, with a "do-not-resuscitate" order, without ETCO2 value or with incomplete data were excluded.
RESULTS: The study population consisted of 668 patients. An ETCO2 value at intubation > 20 mmHg and its increase 10 min after intubation were independent predictors (after correction for known predictors of OHCA outcome) of survival to hospital admission and survival at hospital discharge. Relative to hospital discharge with good neurological outcome, ETCO2 at intubation and its 10-min change were confirmed predictors both individually and in a bivariable analysis (OR 1.83, 95 %CI 1.02-3.3; p = 0.04 and OR 3.9, 95 %CI 1.97-7.74; p < 0.001, respectively). This was confirmed also when accounting for gender, age, etiology and location. After further adjustment for bystander and CPR status, presenting rhythm and EMS arrival time, the ETCO2 change remained an independent predictor.
CONCLUSIONS: ETCO2 value > 20 mmHg at intubation and its increase during resuscitation improve the prediction of survival at hospital discharge with good neurological outcome of OHCA patients. ETCO2 increase during resuscitation is a more powerful predictor than ETCO2 at intubation. A larger prospective study to confirm this finding appears warranted.
参考来源
- Baldi E, Caputo ML, Klersy C, et al. End-tidal carbon dioxide (ETCO2) at intubation and its increase after 10 minutes resuscitation predicts survival with good neurological outcome in out-of-hospital cardiac arrest patients. Resuscitation. 2022. PMID: 36162612. doi:10.1016/j.resuscitation.2022.09.015
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。